Clinical trial
Study To Compare The Efficacy Of Cervical Cytology With Molecular Screening In The Detection Of Reactive Cellular Changes In The Cervix In An Open Population
NCT07211204 is registered in ClinicalTrials.gov with Timser SAPI de CV as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Study To Compare The Efficacy Of Cervical Cytology With Molecular Screening In The Detection Of Reactive Cellular Changes In The Cervix In An Open Population
- Lead sponsor
- Timser SAPI de CV
- Phase
- Not applicable
- Overall status
- Withdrawn
- Start date
- February 27, 2026
- Completion date
- February 27, 2026
- Enrollment
- 0 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
agus, asc-us, atypical glandular cells of uncertain significance, atypical squamous cell of undetermined significance, cervical cancer, cervical intraepithelial neoplasia (cin), cin 1, cin 2, cin 3